Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders. - Wikidata - awgldk - TriplyDB

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

http://www.wikidata.org/entity/Q46722604

about

Rare gastrointestinal lymphomas: The endoscopic investigation Complete response to post-transplant lymphoproliferative disorder by surgical resection and rituximab after living-donor liver re-transplantation for recurrent primary sclerosing cholangitis.Newly emerging therapies targeting viral-related lymphomas.Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.Outcome of rapamycin therapy for post-transplant-lymphoproliferative disorder after kidney transplantation: case series Management of patients with post-transplant lymphoproliferative disorder: the role of rituximab.Review of Epstein-Barr virus and post-transplant lymphoproliferative disorder post-solid organ transplantation.Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.Role of chemotherapy and rituximab for treatment of posttransplant lymphoproliferative disorder in solid organ transplantation.Treatment of post-transplantation lymphoproliferative disorders after kidney transplant with rituximab and conversion to m-TOR inhibitor.Epstein-barr virus-negative post-transplant lymphoproliferative diseases: three distinct cases from a single center Post-transplantation lymphoproliferative disorder (PTLD) twenty years after heart transplantation: a case report and review of the literature.Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.Post-transplant lymphoproliferative disorders following solid-organ transplantation.Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update.Post transplant lymphoproliferative disorders: risk, classification, and therapeutic recommendations.Post-transplant lymphoproliferative disease (PTLD): risk factors, diagnosis, and current treatment strategies.Comparative analysis of post-transplant lymphoproliferative disorder after kidney transplantation versus hematopoietic stem cell transplantation.Epstein-Barr Virus-Positive Posttransplant Lymphoproliferative Disease After Solid Organ Transplantation: Pathogenesis, Clinical Manifestations, Diagnosis, and Management.HLA-DRB1 typing by micro-bead array assay identifies the origin of early lymphoproliferative disorder in a heart transplant recipient.A Rare Presentation of Isolated CNS Posttransplantation Lymphoproliferative Disorder.Didactic lessons from the serum lactate dehydrogenase posttransplant: a clinical vignette.Recursive partitioning analysis of prognostic factors in post-transplant lymphoproliferative disorders (PTLD): a 120 case single institution series.The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.Cerebral pathology post heart transplantation.Colonic diffuse large B-cell lymphoma in a liver transplant patient with historically very low tacrolimus levels.Lowered Immune Cell Function in Liver Recipients Recovered From Posttransplant Lymphoproliferative Disease Who Developed Graft Tolerance.A population-based study of 135 lymphomas after solid organ transplantation: The role of Epstein-Barr virus, hepatitis C and diffuse large B-cell lymphoma subtype in clinical presentation and survival.Post cardiac transplantation T-cell lymphoproliferative disorder presenting as a solitary lung nodule.Response to rituximab-based therapy and risk factor analysis in Epstein Barr Virus-related lymphoproliferative disorder after hematopoietic stem cell transplant in children and adults: a study from the Infectious Diseases Working Party of the Europe Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.Allograft involvement by lymphoproliferative disorders after lung transplantation: report from the PTLD. Int survey.Single-center analysis of biopsy-confirmed posttransplant lymphoproliferative disorder: incidence, clinicopathological characteristics and prognostic factors.Posttransplant lymphoproliferative disorder presenting as multiple cystic lesions in a renal transplant recipient.Hepatosplenic T-cell lymphoma and TNF-α inhibitors.CD20 expression predicts survival in paediatric post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation.Infusions of Epstein-Barr virus-specific cytotoxic T lymphocytes as post-remission therapy in high-risk post-transplant lymphoproliferative disorder patients: report of two cases.Inhibition of mTOR by sirolimus induces remission of post-transplant lymphoproliferative disorders.Posttransplant Lymphoproliferative Disease Presenting as an Extracranial Mass.A Rare Case of Classical Hodgkin Lymphoma Diagnosed 10 Years after Liver Transplant.

P2860

Q26799041-07CF8716-E9AF-4230-8274-D56E5EB68982 Q33436410-A762B08B-AE28-4451-B1F2-CB1CA9C1F4B0 Q33699201-2F575CC6-F966-4CEE-BCED-D9535F115D11 Q33710720-F22CA5C2-E2A7-478E-9286-F60BA565819A Q34668891-3BF9D9E1-D20B-4B93-9AEC-421D256F5627 Q36435819-883B0579-2375-4143-BE52-4783D86764EB Q36556729-2A2C5BB1-C0F2-4504-A6D6-93DD0E092344 Q36732580-4262EF9E-7641-4709-A4FF-D7F9404A622B Q36937549-9FD99CDE-57D9-45B4-986A-47D19D80E989 Q37679263-C569C0B1-AF6D-43C9-9657-2622A3B0686C Q37718389-5F754AC8-07AD-4158-A346-0D3AB4CBA166 Q37730638-3E180BC8-EC2A-402A-9591-F382447D9415 Q37793222-98BDBCB4-0330-4E66-888A-B5E30D4BDFCC Q37810068-E07FF4E7-9DEC-481E-A914-B2992E8B07EF Q37845384-4D66847A-7AAC-4B1C-8B08-32B74FF53ABF Q37975458-9B94B3D0-7DF8-465E-9509-B4C337DE0183 Q38112050-11DBBD68-E9E0-4DB4-9B5D-430D28DA12CE Q38439825-1D249975-4262-479F-A86B-86A6D3CA2C2B Q38833567-D0C4B610-1E9F-47F0-AB86-FD7B8C8F6D20 Q40260373-4389D472-3EE5-4230-A7F8-7F7BD7FC2ADC Q40360743-6F2F789D-C969-43AA-B2EF-C4039399DBAB Q40426421-2F0C223C-FA74-4B5F-9806-29F9CB2607D3 Q41065318-CA4949CF-6746-454C-810A-491BD5133769 Q41219311-05AD3A34-5783-408E-80E4-9D356C008CA9 Q41712366-1BC57DCF-B9FA-46F2-8959-BC36B177C358 Q41726812-DAAF1280-93EC-4932-BD84-742604D8E6D9 Q42053532-9C16DB5D-DA3F-48D3-A9BF-AB54E7E1C6BC Q42242814-1608913D-2668-4A4B-A9CD-02489685244D Q42251789-16DA1B1C-5F6E-4C08-A277-B3AD67A76E94 Q42258745-DB8B59B9-2FE6-44ED-926E-D2CAD849B0DC Q42368054-8185D062-4A29-498A-BCCA-EFCB37A1AA47 Q43559889-F30D2028-DB56-4D52-8B22-B08A40F4321A Q44891160-9EF25203-BE66-4E53-9D26-66F7087A1BEE Q44964154-B1AA5CCB-27CC-4C94-9EF4-31735EB8E784 Q45207777-E1FCB940-5A39-4959-B099-407B239C2B54 Q45279494-C3AFAD0F-3045-424B-AABA-060DB9C1A3C1 Q45324037-33E65EE6-E294-4012-8FE0-A8853EF5D3E0 Q46747428-E35E3170-63B2-4300-B6D4-F5064C247B97 Q47137019-5F3CF96B-5BCE-4F85-9AD4-94213CB3C73F Q47138068-36D76C3E-295E-40C0-A63D-4C6FA1F60EC8

P2860

Prognostic analysis for survival in adult solid organ transplant recipients with post-transplantation lymphoproliferative disorders.

http://www.wikidata.org/entity/Q46722604

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Prognostic analysis for surviv ...... lymphoproliferative disorders.

@en

Prognostic analysis for surviv ...... lymphoproliferative disorders.

@nl

type

label

Prognostic analysis for surviv ...... lymphoproliferative disorders.

@en

Prognostic analysis for surviv ...... lymphoproliferative disorders.

@nl

prefLabel

Prognostic analysis for surviv ...... lymphoproliferative disorders.

@en

Prognostic analysis for surviv ...... lymphoproliferative disorders.

@nl

P1433

Q46722604-066C7DE6-993F-440C-AA95-94BB8191046E

P1476

Q46722604-BD086E2A-8589-4F22-AA36-2ECE23E8525B

P2093

Q46722604-11A947C3-F79C-4E3C-9467-DC53710272D9

Q46722604-2EE890B6-C5C5-4D9A-810B-1F1EF8D3E98A

Q46722604-421DDA99-904C-4DF4-86F7-94E038BE6775

Q46722604-73140A9F-D7ED-49E3-87F5-75324A312F66

Q46722604-86168D42-44A1-4476-A5DE-FA68DCE5553D

Q46722604-97F01FF2-FD26-45E0-9A53-4BD5A1D879E8

Q46722604-B1D2A00F-E06C-41B3-8FE5-A3831DEBCB71

Q46722604-BCDEB568-60C6-4900-A282-EE6F0A461F2B

Q46722604-C734BD96-C7F0-43AC-97D7-6C0E0BB228D3

Q46722604-D1CA6452-D93D-46C3-A613-8D40B00E5580

P304

Q46722604-11A5F8B7-FE73-49A8-AAD2-33B4CACF8541

P31

Q46722604-62D7E24D-FB55-4EB2-A6EC-B2B17A318ACD

P356

Q46722604-BE024052-329E-457F-9884-9AC6AFC78338

P407

Q46722604-BFB49D8E-C090-41B2-BC12-D0438C18501D

P433

Q46722604-FE0FC044-404E-4940-8E99-934BCCCBCAF7

P478

Q46722604-469A9253-1507-4225-8440-DC548F8ABE12

P50

Q46722604-48A78EEE-BAD9-4687-B335-A7C76BB7CB1B

P577

Q46722604-4691859E-2C56-4AA5-8387-3D7109A77D47

P5875

Q46722604-E965EA35-9644-4519-A5F2-228BD7445933

P698

Q46722604-FF98F6FC-9E05-4FC1-B295-22C0E22995AD

P356

JCO.2005.01.0934

P1433

Journal of Clinical Oncology

P1476

Prognostic analysis for surviv ...... lymphoproliferative disorders

@en

P2093

Christopher G McGregor

http://www.w3.org/2001/XMLSchema#string

Gregory G Gores

http://www.w3.org/2001/XMLSchema#string

Irene M Ghobrial

http://www.w3.org/2001/XMLSchema#string

Kay M Ristow

http://www.w3.org/2001/XMLSchema#string

Mark D Stegall

http://www.w3.org/2001/XMLSchema#string

Randall C Walker

http://www.w3.org/2001/XMLSchema#string

Stephen M Ansell

http://www.w3.org/2001/XMLSchema#string

Susan M Geyer

http://www.w3.org/2001/XMLSchema#string

Thomas M Habermann

http://www.w3.org/2001/XMLSchema#string

Timothy S Larson

http://www.w3.org/2001/XMLSchema#string

P304

7574-7582

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1200/JCO.2005.01.0934

http://www.w3.org/2001/XMLSchema#string

P407

P433

30

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Matthew J Maurer

P577

2005-09-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7577070

http://www.w3.org/2001/XMLSchema#string

P698

16186599

http://www.w3.org/2001/XMLSchema#string